Filing Details
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2009-03-19 08:00:18
- Reporting Period:
- 2009-03-17
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 934936 | Scolr Pharma Inc. | DDD | () |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1024533 | N Michael Taglich | C/O Scolr Pharma, Inc. 19204 North Creek Parkway, Suite 100 Bothell WA 98011 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2009-03-17 | 2,500 | $0.25 | 440,785 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
